Skip to content

Public FDA record

Z-2865-2016: Merge Cardio software. Product Usage: Merge Cardio is an integrated cardiovascular information system

Recall record Z-2865-2016 for Merge Healthcare, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2865-2016
Company in FDA record
Merge Healthcare, Inc.
FDA record creation date
Sep 21, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Patient information in the header is only found on the first page of the report and not on the subsequent pages.

Source facts

Action
Merge sent an Urgent Medical Device Recall letter dated January 28, 2016 to affected customers via e-mail or via certified mail if they did not have an e-mail address. The letter identified the affected product, problem and actions to be taken. For questions call Merge Customer Service at (877)741-5369 or support@merge.com.
Initiated
2016-01-30
Root cause
Software design
Terminated
2017-12-15
Distribution
US Nationwide Distribution
Recall number
Z-2865-2016
Recall status
Terminated
CDRH record ID
149148
FDA record created
2016-09-21
Recall event number
75034

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗